Buy Marker Therapeutics Inc Stock | MRKR Stock Price & Latest News | Public
MRKR

Marker Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About MRKR

    Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.05
    -0.11
    -0.16
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.16

    Actual EPS
    Q4 2020

    Stats

    Market Cap$81,16M
    Volume4,49k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.43
    1 Year Low$1.32
    Open$1.70
    High$1.71
    Low$1.65

    Buy any stock with any amount of money.

    Download the App
    Download the app